Randal Alexander Serafini

Title: Randal Alexander Serafini: Innovator in Ocular Evaluation Technologies

Introduction

Randal Alexander Serafini is a notable inventor based in New York, NY (US). He has made significant contributions to the field of ocular evaluations, holding a total of 3 patents. His innovative work focuses on enhancing the methods and technologies used in eye care and assessments.

Latest Patents

One of Serafini's latest patents is the "Modular platform for ocular evaluations." This screening platform enables comprehensive ocular evaluations and includes a harness designed to fit a patient's head. It features electronic components that power an interchangeable module, a central processing unit (CPU) with a graphical processing unit (GPU), and communication capabilities with external devices. The platform allows for multiple display outputs and various input devices from both the operator and the patient, with the interchangeable module being separable from the screening platform.

Another significant patent is the "Head-mounted system for measuring ptosis." This method predicts visual field loss by defining a superior visual field in a coordinate system. The process involves displaying and recording data for specific columns, defining an eyelid meridian based on recorded coordinates, and calculating the area of the superior visual field to determine visual field loss.

Career Highlights

Randal Serafini has worked with esteemed organizations such as the Icahn School of Medicine at Mount Sinai and Matrixmed Inc. His experience in these institutions has allowed him to develop and refine his innovative technologies in ocular evaluations.

Collaborations

Throughout his career, Serafini has collaborated with talented individuals, including Margarita Labkovich and Andrew Jinrui Warburton. These collaborations have contributed to the advancement of his inventions and the impact they have on the field.

Conclusion

Randal Alexander Serafini is a distinguished inventor whose work in ocular evaluation technologies has the potential to transform eye care practices. His patents reflect a commitment to innovation and improving patient outcomes in ocular health.